SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 35.53 |
Enterprise Value ($M) | 34.54 |
Book Value ($M) | -7.23 |
Book Value / Share | -0.21 |
Price / Book | -4.92 |
NCAV ($M) | -7.23 |
NCAV / Share | -0.21 |
Price / NCAV | -4.92 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | n/a |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.28 |
Current Ratio | 0.28 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2.83 |
Assets | 2.83 |
Liabilities | 10.05 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
25,275 | 72,392 | 34.91 | |
15,649 | 51,323 | 30.49 | |
15,369 | 79,388 | 19.36 | |
91,515 | 278,385 | 32.87 | |
(click for more detail) |
Similar Companies | |
---|---|
OCEA – Ocean Biomedical, Inc. | OCGN – Ocugen, Inc. |
OCX – OncoCyte Corporation | ONCO – Onconetix, Inc. |
ONCY – Oncolytics Biotech Inc. |
Financial data and stock pages provided by
Fintel.io